Trial
NCT05838703
Tiotropium Handihaler vs. Tiotropium Respimat in COPD
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
—
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Intervention
tiotropium bromide inhalation powder (Spiriva HandiHaler)
Why stopped
Study halted prematurely due to funding, prior to enrollment of first participant
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-15